First results of a quantitative study of DNA adducts of melphalan in the rat by isotope dilution mass spectrometry using capillary liquid chromatography coupled to electrospray tandem mass spectrometry

Rapid Commun Mass Spectrom. 2005;19(14):1999-2004. doi: 10.1002/rcm.2018.

Abstract

Rats were intravenously injected with a single high dose (10 mg/kg) of the alkylating agent melphalan in order to study DNA-adduct formation. Quantitation of a dGuo-melphalan adduct was done by isotope dilution mass spectrometry using capillary liquid chromatography/mass spectrometry (LC/MS) and [15N5]-labeled dGuo-melphalan as internal standard. DNA-adduct levels were studied in bone marrow, liver and kidney. The instrumental detection limit of the method was determined to be 900 fg (S/N 3, pure standard). These first results clearly show a 10 times higher adduct level in bone marrow compared to kidney and a 6 times higher level compared to liver. More experiments will be necessary to gather more information on the pharmacokinetics of melphalan-DNA adducts under in vivo conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Alkylating / analysis*
  • Antineoplastic Agents, Alkylating / chemistry
  • Chromatography, Liquid / methods*
  • DNA Adducts / analysis*
  • Melphalan / analysis*
  • Melphalan / chemistry
  • Nitrogen Isotopes / analysis
  • Rats
  • Rats, Wistar
  • Spectrometry, Mass, Electrospray Ionization / methods*

Substances

  • Antineoplastic Agents, Alkylating
  • DNA Adducts
  • Nitrogen Isotopes
  • Melphalan